Commotio Retinae
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120636) | Targeted Therapy Technologies, LLC | 2021-03-05 |
| Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120311) | Targeted Therapy Technologies, LLC | 2019-09-01 |
Track Commotio Retinae automatically
Every clearance here is in the API, with alerts when new ones post.